MS Views and News – a Patient Advocacy Organization that provides educational information for ALL affected by Multiple Sclerosis

Being Empowered with MS information IS beneficial.

Visit our archived education program video recordings. Visit www.youtube.com/msviewsandnews

Visit our website: MS Views and News.org

joomla ecommerce template

Scroll to Review all the resources found on the left side of this blog site. Use our 'search by topic' tool, when wanting to find specific information

.

==================================

Wednesday, November 14, 2012

Nuron closing in on new treatment for relapsing MS


Tuesday, November 13, 2012
Nuron Biotech Inc. said Tuesday it has completed enrollment of 500 patients for a pivotal phase-III study evaluating the safety and effectiveness of the company’s experimental multiple sclerosis treatment.
Phase-III studies are typically the last hurdle a drug developer must clear before seeking approval for a new drug candidate.
Nuron, an Exton, Pa., specialty biologics and vaccines company, is developing NU100 to treat relapsing remitting multiple sclerosis.
Shankar Musunuri, the company’s founder and CEO, said it expects to complete the study in late 2013.
The company hopes to use the results of the study to support the filing of a European marketing authorization application.
Source: BizJournals

..


If you would like, you can comment to our blog posts
 LIKE this Blog by clicking the LIKE button - top left
 REMAIN up to date with MS News and Education
Visit: www.msviewsandnews.org  to register
.

No comments: